Skip to main content

What's New

NIDDK
NIDDK Program Officials with Expertise in Translational Research The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is hiring program officials with expertise in translational research involving stem cell biology, regenerative medicine and human pathophysiology as it relates to Diabetes, Endocrinology and Metabolic Diseases.
NIDDK
NIDDK Program Director for Diabetes Behavioral Science Position The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is seeking a Clinical Health Psychologist to lead a program of behavioral research on diabetes within the Division of Diabetes, Endocrinology and Metabolic Diseases.
NIH
NCBI SARS-CoV-2 Resources The National Center for Biotechnology Information (NCBI) provides access to NCBI SARS-CoV-2 literature, sequence, and clinical content.
Roger H. Unger, M.D., visionary endocrinologist and preeminent authority on diabetes: 1924-2020 Roger Unger, who studied the hormonal underpinnings of diabetes for more than 60 years, died on August 22 at age 96. During his long tenure at the University of Texas Southwestern (UTSW) Medical Center that ended in July when he retired, he discovered the roles of the hormones glucagon and insulin in controlling blood sugar levels in the body.
NIDDK
Request for Information: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Strategic Plan The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is embarking on an Institute-wide strategic planning process. The goal of the process is to develop a broad vision for accelerating research into the causes, prevention, and treatment of diseases and conditions within the Institute’s mission. This overarching trans-NIDDK Strategic Plan will complement NIDDK’s disease-specific planning efforts. The strategic plan will have a 5-year time horizon but will also include planning for longer term efforts that could be initiated within this time frame.
NIH
Request for Information: Challenges and Opportunities in Understanding Cellular Senescence and Senolytics The NIH is considering the possibility of developing a Common Fund program to address the role of senescent cells in health and disease. In spite of the burgeoning efforts already in the field attempting to test therapies based on attacking senescent cells, it has become clear that many aspects of cell senescence research are currently in need of answers before the full potential of such therapies can be safely developed in humans. As part of the initial planning process, we are requesting input from the scientific community on the challenges in this field that can best be addressed through a concerted and coordinated effort.
NIH
MMRRC Announces Acquisition of KOMP Repository The Mutant Mouse Resource and Research Center (MMRRC), the official National Institute of Health (NIH) repository of mouse models, is pleased to announce the availability of genetically-altered mice and embryonic stem (ES) cells made as part of the NIH Knockout Mouse Project (KOMP) and previously maintained in the KOMP Repository.
NIDDK
NIDDK Recent Advances & Emerging Opportunities 2020 The publication, NIDDK Recent Advances & Emerging Opportunities, is a report that the NIDDK has issued annually since 2001. It is a compendium that highlights examples of the many research advances published by NIDDK-funded scientists and their colleagues.
NIDDK
dkNET: Connecting Researchers to Resources The NIDDK Information Network (dkNET), is a search portal and information hub that helps researchers find research resources and data repositories relevant to their research and keep up to date on new tools, services and mandates to support robust and reproducible science, including funding opportunities, resource authentication and data sharing.
Summer 2019 Type 2 Diabetes Knowledge Portal Newsletter The Summer 2019 T2D Knowledge Portal Newsletter lists upcoming webinars, new videos, and venues, plus articles on mining genomic data, genetic association analysis, and burden test improvements.
NIDDK
Request for Information (RFI): Regarding Bioinformatics/Computational Needs for NIDDK Investigators Engaged in Diabetes, Endocrinology and Metabolic Diseases Research The National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK) invites interested investigators to provide input on their needs for bioinformatics/computational support to advance R01-based research in Diabetes, Endocrinology and Metabolic Diseases. Responses to this RFI will be accepted through October 15, 2019.
NIDDK
NIDDK Special Job Announcements 2019 The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a component of the National Institutes of Health (NIH), are looking for applicants with significant research experience, who have a commitment to excellence, and the energy, enthusiasm, and innovative thinking necessary to lead dynamic and diverse programs. Applicants must be U.S. Citizens.